(Q53904782)

22 May 2018

title

Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients. (English)

1 reference

22 May 2018

adult-onset Still's disease

main subject

1 reference

6

Petros P Sfikakis

1 reference

22 May 2018

Nicholas Katsilambros

5

object named as

Nicholas Katsilambros

1 reference

22 May 2018

author name string

Alexander Kokkinos

1

1 reference

22 May 2018

Alexios Iliopoulos

2

1 reference

22 May 2018

Paraskevi Greka

3

1 reference

22 May 2018

Anna Efthymiou

4

1 reference

22 May 2018

publication date

15 November 2003

1 reference

22 May 2018

published in

Clinical Rheumatology

1 reference

22 May 2018

volume

23

1 reference

22 May 2018

issue

1

1 reference

22 May 2018

page(s)

45-49

1 reference

22 May 2018

Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis

cites work

1 reference

12 December 2020

Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study

1 reference

12 December 2020

Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002).

1 reference

12 December 2020

Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases

1 reference

12 December 2020

Preliminary criteria for classification of adult Still's disease

1 reference

12 December 2020

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

12 December 2020

Adult Still's disease with Sjögren's syndrome successfully treated with intravenous pulse methylprednisolone and oral cyclophosphamide

1 reference

12 December 2020

Infliximab in the treatment of adult Still's disease refractory to conventional therapy

1 reference

12 December 2020

Behçet's disease: a new target for anti-tumour necrosis factor treatment

1 reference

12 December 2020

Transmembrane TNF-alpha, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn's disease

1 reference

12 December 2020

Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy.

1 reference

12 December 2020

Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease

1 reference

12 December 2020

Adult onset Still's disease associated hemophagocytosis

1 reference

12 December 2020

Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures

1 reference

12 December 2020

Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes

1 reference

12 December 2020

A case of adult onset Still's disease treated with infliximab

1 reference

12 December 2020

Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease

1 reference

12 December 2020

Etanercept in the treatment of adult patients with Still's disease

1 reference

12 December 2020

Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease

1 reference

12 December 2020

Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents

1 reference

12 December 2020

Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences

1 reference

12 December 2020

Management of Crohn's disease in adults

1 reference

12 December 2020

Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease

1 reference

12 December 2020

Severe systemic inflammatory response syndrome with shock and ARDS resulting from Still's disease: clinical response with high-dose pulse methylprednisolone therapy

1 reference

12 December 2020

10.1007/S10067-003-0775-5

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018